Search

Search Constraints

You searched for: Author/Creator Irving, William L.

Search Results

2. Comprehensive Comparative Analysis of Standard Validated, Genetic, and Novel Biomarkers to Enhance Prognostic Risk-Stratification in Patients With Hepatitis C Virus Cirrhosis. Issue 3 (9th March 2022)

3. Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK. (20th February 2023)

4. Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes. Issue 1 (30th March 2016)

5. Enterovirus D68 epidemic, UK, 2018, was caused by subclades B3 and D1, predominantly in children and adults, respectively, with both subclades exhibiting extensive genetic diversity. Issue 5 (9th May 2022)

6. Expression of human ficolin-2 in hepatocytes confers resistance to infection by diverse hepatotropic viruses. Issue 4 (12th February 2019)

7. Geographical variation in hepatitis C-related severe liver disease and patient risk factors: a multicentre cross-sectional study. (14th March 2023)

8. Hepatitis C subtyping assay failure in UK patients born in sub‐Saharan Africa: Implications for global treatment and elimination. Issue 1 (8th October 2022)

9. Human parainfluenza 2 & 4: Clinical and genetic epidemiology in the UK, 2013–2017, reveals distinct disease features and co‐circulating genomic subtypes. Issue 6 (7th June 2022)

10. Is increased hepatitis C virus case‐finding combined with current or 8‐week to 12‐week direct‐acting antiviral therapy cost‐effective in UK prisons? A prevention benefit analysis. Issue 6 (22nd March 2016)